SIGA Technologies
SIGA
#8710
Rank
โ‚ฌ0.19 B
Marketcap
2,75ย โ‚ฌ
Share price
-0.79%
Change (1 day)
-54.92%
Change (1 year)

SIGA Technologies (SIGA) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : โ‚ฌ59.53 Million

According to SIGA Technologies's latest financial reports the company's total liabilities are โ‚ฌ59.53 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

SIGA Technologies - Total liabilities on balance sheet (from 2001 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31โ‚ฌ17.57 M-35.9%
2024-12-31โ‚ฌ27.41 M-47.28%
2023-12-31โ‚ฌ52 M124.27%
2022-12-31โ‚ฌ23.19 M-35.01%
2021-12-31โ‚ฌ35.68 M119.04%
2020-12-31โ‚ฌ16.29 M-81.89%
2019-12-31โ‚ฌ89.96 M2.38%
2018-12-31โ‚ฌ87.87 M-77.46%
2017-12-31โ‚ฌ0.38 B-8.54%
2016-12-31โ‚ฌ0.42 B-0.86%
2015-12-31โ‚ฌ0.43 B28.42%
2014-12-31โ‚ฌ0.33 B161.47%
2013-12-31โ‚ฌ0.12 B118.31%
2012-12-31โ‚ฌ58.65 M53.56%
2011-12-31โ‚ฌ38.2 M239.58%
2010-12-31โ‚ฌ11.24 M-14.1%
2009-12-31โ‚ฌ13.09 M152.78%
2008-12-31โ‚ฌ5.18 M41.12%
2007-12-31โ‚ฌ3.67 M-28.19%
2006-12-31โ‚ฌ5.11 M110.72%
2005-12-31โ‚ฌ2.42 M112.14%
2004-12-31โ‚ฌ1.14 M162.63%
2003-12-31โ‚ฌ0.43 M-30.71%
2002-12-31โ‚ฌ0.62 M-16.7%
2001-12-31โ‚ฌ0.75 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Sarepta Therapeutics
SRPT
โ‚ฌ1.47 B 2,370.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
โ‚ฌ1.04 B 1,652.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
โ‚ฌ48.34 M-18.80%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
โ‚ฌ0.93 M-98.43%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
โ‚ฌ0.89 B 1,403.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚ฌ0.70 B 1,076.54%๐Ÿ‡บ๐Ÿ‡ธ USA